LAIR-1 overexpression inhibits epithelial–mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism

[1]  Jie Fang,et al.  Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation , 2020, Journal of Cancer.

[2]  Huiming Ju,et al.  Effects of Porcine STC-1 on Cell Metabolism and Mitochondrial Function. , 2020, General and comparative endocrinology.

[3]  K. Biswas.  Molecular Mobility-Mediated Regulation of E-Cadherin Adhesion. , 2019, Trends in biochemical sciences.

[4]  R. D. da Silva,et al.  Stanniocalcin-1 and -2 effects on glucose and lipid metabolism in white adipose tissue from fed and fasted rats. , 2019, Canadian journal of physiology and pharmacology.

[5]  Zhengyu Li,et al.  Up-regulated of Angiopoietin-Like Protein 4 Predicts Poor Prognosis in Cervical Cancer , 2019, Journal of Cancer.

[6]  Yonglian Guo,et al.  Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway , 2019, Journal of bone oncology.

[7]  Q. Fu,et al.  Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma. , 2019, Current problems in cancer.

[8]  S. Nechaev,et al.  PARP-1/2 Inhibitor Olaparib Prevents or Partially Reverts EMT Induced by TGF-β in NMuMG Cells , 2019, International journal of molecular sciences.

[9]  Minu Singh,et al.  Low Expression of Leucocyte Associated Immunoglobulin Like Receptor-1 (LAIR-1/CD305) in a Cohort of Pediatric Acute Lymphoblastic Leukemia Cases , 2018, Asian Pacific journal of cancer prevention : APJCP.

[10]  H. Knowles,et al.  Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis , 2018, BMC Cancer.

[11]  G. Yin,et al.  MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7. , 2017, Archives of biochemistry and biophysics.

[12]  Xiaofei Ji,et al.  The leukocyte-associated immunoglobulin (Ig)-like receptor-1 modulating cell apoptosis and inflammatory cytokines secretion in THP-1 cells after Helicobacter pylori infection. , 2017, Microbial pathogenesis.

[13]  Daoqing Wang,et al.  High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma. , 2017, Pathology, research and practice.

[14]  N. Tan,et al.  Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial–mesenchymal transition by inducing 14-3-3γ expression , 2017, Oncogene.

[15]  Guoxing Xu,et al.  TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway , 2017, Scientific Reports.

[16]  Z. Chen,et al.  Multiple biological functions of Twist1 in various cancers , 2017, Oncotarget.

[17]  P. Liu,et al.  FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition , 2016, Oncotarget.

[18]  Yue Wang,et al.  Clinical significance of leukocyte-associated immunoglobulin-like receptor-1 expression in human cervical cancer , 2016, Experimental and therapeutic medicine.

[19]  Hongtao He,et al.  Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression , 2016, Oncotarget.

[20]  Yihe Hu,et al.  Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with different phases of osteosarcoma. , 2015, Oncology letters.

[21]  X. Luan,et al.  Leukocyte-associated immunoglobulin-like receptor-1 expressed in epithelial ovarian cancer cells and involved in cell proliferation and invasion. , 2015, Biochemical and biophysical research communications.

[22]  M. Okada,et al.  Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells , 2014, Oncotarget.

[23]  Yan Zhou,et al.  p21-activated kinase 7 is an oncogene in human osteosarcoma , 2014, Cell biology international.

[24]  Shiqing Liu,et al.  hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics , 2013, Oncology letters.

[25]  Young‐Mi Lee,et al.  Downregulation of ERK signaling impairs U2OS osteosarcoma cell migration in collagen matrix by suppressing MMP9 production , 2013, Oncology letters.

[26]  M. Masutani,et al.  Poly(ADP-ribosyl)ation in carcinogenesis. , 2013, Molecular aspects of medicine.

[27]  Sung Soo Kim,et al.  Cancer cell metabolism: implications for therapeutic targets , 2013, Experimental & Molecular Medicine.

[28]  Marie-Pier Tétreault,et al.  Krüppel-like factors in cancer , 2013, Nature Reviews Cancer.

[29]  L. Szablewski.  Expression of glucose transporters in cancers. , 2013, Biochimica et biophysica acta.

[30]  Y. Zhang,et al.  Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis , 2013, Clinics.

[31]  F. Dantzer,et al.  Poly(ADP-ribose)-dependent regulation of Snail1 protein stability , 2011, Oncogene.

[32]  T. de Ruiter,et al.  Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1. , 2011, Molecular immunology.

[33]  H. Li,et al.  Increased 18F-FDG uptake and expression of Glut1 in the EMT transformed breast cancer cells induced by TGF-beta. , 2010, Neoplasma.

[34]  M. Gobbi,et al.  Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division , 2008, Leukemia.

[35]  L. Meyaard.  The inhibitory collagen receptor LAIR‐1 (CD305) , 2008, Journal of leukocyte biology.

[36]  L Meyaard,et al.  LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. , 1997, Immunity.

[37]  J. Henzen.  Publisher's note , 1979, Brain Research.